Table of Contents:

Ashton Tweed Welcomes New Global Clients

BioPortUSA Travels to Italy

Ernst and Young Celebrates Local Entrepreneurs

Industry Trends

Upcoming Conferences

Archived
Newsletters

May, 2007
March, 2007
December, 2006
October, 2006
July, 2006
May, 2006
March, 2006
January, 2006
November, 2005
September, 2005
July, 2005
May, 2005
March, 2005
January, 2005

Back to Newsletters

Ashton Tweed Welcomes New Global Clients

Ashton Tweed is pleased to announce that we have expanded our client base to include two international drug development companies who are establishing their U.S. commercial operations in the Tri-state area. Both of these clients develop pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. Our clients’ newly established U.S. commercial business units will promote niche products in targeted therapeutic areas.

During their recent visit to Italy, Jim Laird and Jordan Warshafsky visited our Italian client and met with some of their key executives. Ashton Tweed will recruit and hire a number of key management positions for this Italian headquartered company. For this client, we are currently recruiting for the following positions:

• U.S. Director/VP Medical,
• U.S. Director of Regulatory Affairs,
• Director of Marketing, and
• Marketing Project Manager.

We invite qualified candidates to submit their resumes to info@ashtontweed.com.

Our second international client is a Canadian drug development company. We are recruiting for the following positions:

• Strategic Marketing,
• Marketing Intelligence, and
• Alliance Management.

We invite qualified candidates to submit their resumes to info@ashtontweed.com.

"With the addition of our new Italian and Canadian clients, Ashton Tweed is pleased to expand our focus globally. We believe our combined capabilities of retained executive search, interim executive talent and commercialization management consulting uniquely position us to meet the needs of international life sciences companies in the United States. The breadth of talent in our exclusive Executive Talent Bank includes highly skilled talent with track records of success in global companies. Our commitment to international life sciences companies is also underscored in our partnership in BioPortUSA," said CEO Jim Rudman.

To learn more about Ashton Tweed’s services and our Executive Talent Bank, please visit www.ashtontweed.com/executive_bank.php.

1. Immediate access to highly skilled talent
Our Executive Talent Bank is the first dedicated to the Life Sciences Industry.

2. Diverse range of options for human capital and commercialization management needs
Our services include interim talent, retained executive search and commercialization consulting.

3. Significant Life Sciences Industry experience
Our partners have diverse backgrounds in the Life Sciences Industry and understand the specific challenges Life Sciences clients face.

4. Personal attention
Each client and candidate receives personal attention by a member of our Leadership Team.

INDUSTRY TRENDS

Recruiter Confidence High

Despite slowing GDP growth, ExecuNet's Recruiter Confidence Index (RCI) revealed that nearly 75% of executive search professionals believe the executive employment market will experience sustained growth over the next six months.

Executive recruiters' short-term outlook is also positive with the executive recruiting industry expecting a 23% increase in the number of assignments received from clients over the next three months.

BioPortUSA Travels to Italy

BioPortUSA, a commercialization accelerator for life sciences companies entering the United States market, has been on the move since its launch at the BIO 2007 International Convention in Boston. While at BIO 2007, BioPortUSA’s CEO Jim Laird and COO Jordan Warshafsky were kept busy with a full slate of meetings with global companies looking to commercialize in the United States.

As an outcome of these meetings, Jordan Warshafsky and Jim Laird traveled in July to Milan and Parma to meet with Italian life sciences companies. In Italy, Jim and Jordan were pleased to find that the BioPortUSA partnership of service providers working together to simplify U.S. market entry was well received by Italian companies considering coming to the United States.

"Our visit to Italy allowed us to see how Italian bioscience companies work firsthand and granted us valuable insight into the Italian market. Because of our visit, we better understand the needs of Italian companies that are considering commercializing their products in the United States," said BioPortUSA CEO Jim Laird.

Rather than trying to navigate U.S. market entry on their own, foreign-based companies can take advantage of BioPortUSA's coordinated services to simplify the U.S. market entry process. By engaging BioPortUSA, client companies can access a menu of core professional services all in one place that will enable them to correctly determine their early investment and accelerate the commercialization process for their product lines.

To learn more about BioPortUSA and its services for companies entering the United States market, please visit www.bioportusa.com.

Back to top

Pennsylvania Bio -
Board Development and Corporate Governance for Bioscience Companies Panel Discussion and Networking Reception - August 15, 2007
The Desmond Hotel Malvern, PA

Ashton Tweed is a co-sponsor of this event featuring a panel of life sciences experts who will explore the development, evolution, and strategic impact of boards of directors of bioscience companies.

The discussion will cover topics including the function and ideal make-up of boards of directors and the best ways for management to work with the board.

The panel will also discuss the "best practices" of establishing good corporate governance policies for companies of various sizes and at various stages.

The program will be followed by a networking reception. To register, please visit the event website.

EuroBio Lille - September 26-28, 2007

EuroBiOpartnering is a business convention and catalyst for technology transfer projects. It also encourages and supports inter-company and business-academic laboratory research collaboration.

This year, EuroBiOpartnering should result in 1,000 business meetings. The conference features 40 lectures bringing together more than 200 speakers of world renown.

The participants will be united around 4 themes:

- Business development and the economics of biotechnology
- "Red" biotechnology
- "White" and "green" biotechnology
- Regulatory affairs, technology transfer and intellectual rights.

For more information, please visit the Eurobio website.

Ernst and Young Celebrates Local Entrepreneurs

On Thursday, June 21, the Philadelphia business community gathered to honor outstanding entrepreneurs from eight distinct business categories at the Ernst & Young Entrepreneur of the Year Award. The regional awards ceremony celebrates people who are building and leading successful, growing, and dynamic businesses and is part of a series of Entrepreneur of the Year Award programs in 125 cities in 40 countries. The Greater Philadelphia region ceremony celebrated 29 entrepreneurs from the consumer products, business services, emerging, health care products & services, life sciences, master, services and software & technology categories.

Ashton Tweed partner Jim Laird attended the ceremony. "I was impressed by the breadth of contributions the leaders of companies in the life sciences industry are making in the Philadelphia region. It is heartening to see how many fine entrepreneurs are helping to shape the industry. Each award winner tonight really demonstrates why the Greater Philadelphia region is an economic success and an excellent place for life sciences companies to grow."

The finalists in the Life Sciences and Healthcare Products & Services sectors included Jack Tighe, President of TMG Health Inc.; Randy Thurman, Chairman of Viasys Healthcare, Inc.; Nicholas Nicolaides, President of Morphotek, Inc.; Steven Nichtberger, President of Tengion, Inc., and Shawn O’Brien, President and CEO of Solstice Neurosciences, Inc.

The evening’s guest speaker was Richard E. Caruso, Ernst & Young 2006 United States Entrepreneur of the Year Award winner and Chairman and Founder of Integra Life Sciences Corporation. Congratulations to Nicholas Nicolaides of Morphotek, Inc. and Randy Thurman of VIASYS who took home the award in the Life Sciences and Healthcare Products and Services Sections.

For more information on the Ernst & Young Entrepreneur of the Year Program, please visit Ernst & Young's Entrepreneur of the Year Awards Overview page.

Back to top

Back to Newsletters

UPCOMING EVENTS

Biotech 2007 DE NJ PA October 8-9, 2007
Loews Philadelphia Hotel,
Philadelphia, PA

Biotech 2007 is designed to advance the growth and development of the bioscience industry in the Mid-Atlantic region and will facilitate networking opportunities among emerging companies, researchers, and large pharmaceutical companies, as well as with cutting-edge support organizations.

For more details, please visit the event website.